Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Úrsula Baños Roldán"'
Autor:
Beatriz Mora Rodríguez, María Carmen Martínez Díaz, Juan Francisco Marín Pozo, Begoña Muros de Fuentes, Paz Quesada Sanz, Fátima Artime Rodríguez-Hermida, María José Martínez Bautista, Úrsula Baños Roldán, José Carlos Roldán Morales, Patricia Rodríguez Gómez, María Teresa Garrido Martínez, Ana I. Sánchez, Juan Manuel Duarte Pérez, Macarena Merino Almazán, Rosa Villatoro Roldán, Antonio Rueda Ramos, Ángel Inoriza Rueda, José Miguel García, Margarita Garrido Siles, Pablo Nieto Guindo, Ana Laura Ortega Granados, Silvia Maria Artacho Criado
Publikováno v:
International Journal of Clinical Pharmacy. 41:272-279
Background Immunotherapy has become a standard treatment for lung cancer; however, the high cost makes it necessary to assess health outcomes. Objective The aim of this study was to evaluate the effectiveness, safety and economic cost of nivolumab in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f67e26579b7c8fc66dbd5522f8d63a81
https://doi.org/10.1007/s11096-018-0772-z
https://doi.org/10.1007/s11096-018-0772-z
Autor:
María de la O Caraballo-Camacho, Jaime Gómez-González, María Dolores Alvarado-Fernández, X Badia, Miguel Ángel Calleja-Hernández, Ana Melcón-de Dios, José Antonio Marcos-Rodríguez, Luis de la Cruz-Merino, José Manuel Galiana-Auchel, Úrsula Baños Roldán, Jaime Cordero-Ramos
Publikováno v:
International journal of technology assessment in health care. 34(5)
Objectives:The aim of this study was to develop and to assess a specific Multi-Criteria Decision Analysis (MCDA) framework to evaluate new drugs in an hospital pharmacy and therapeutics committee (P&TC) setting.Methods:A pilot criteria framework was
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a39c3ada660b746bfa82c1eeb1282939
https://pubmed.ncbi.nlm.nih.gov/30348241
https://pubmed.ncbi.nlm.nih.gov/30348241